# Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

> **NCT00226447** · PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 30 (—)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Pegylated Interferon
- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT00226447
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226447, "Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00226447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*